U.S. markets close in 1 hour 58 minutes
  • S&P 500

    3,847.15
    -23.14 (-0.60%)
     
  • Dow 30

    31,471.36
    +79.84 (+0.25%)
     
  • Nasdaq

    13,095.07
    -263.72 (-1.97%)
     
  • Russell 2000

    2,239.35
    +7.84 (+0.35%)
     
  • Crude Oil

    61.64
    +1.89 (+3.16%)
     
  • Gold

    1,718.50
    -15.10 (-0.87%)
     
  • Silver

    26.41
    -0.47 (-1.76%)
     
  • EUR/USD

    1.2076
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.4720
    +0.0570 (+4.03%)
     
  • GBP/USD

    1.3971
    +0.0015 (+0.10%)
     
  • USD/JPY

    106.9480
    +0.2380 (+0.22%)
     
  • BTC-USD

    51,235.84
    +3,295.61 (+6.87%)
     
  • CMC Crypto 200

    1,025.98
    +37.88 (+3.83%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Recap: Varian Medical Systems Q1 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Varian Medical Systems (NYSE:VAR) were flat in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share decreased 1.72% year over year to $1.14, which beat the estimate of $1.10.

Revenue of $778,800,000 decreased by 6.04% year over year, which missed the estimate of $842,980,000.

Looking Ahead

Varian Medical Systems hasn't issued any earnings guidance for the time being.

View more earnings on VAR

Varian Medical Systems hasn't issued any revenue guidance for the time being.

Recent Stock Performance

52-week high: $176.19

52-week low: $89.62

Price action over last quarter: Up 1.71%

Company Profile

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.